OMESIL

This brand name is authorized in Nigeria.

Active ingredients

The drug OMESIL contains one active pharmaceutical ingredient (API):

1	Omeprazole UNII KG60484QX9 - OMEPRAZOLE
	Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.
	Read more about Omeprazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-4018	Capsule	Omesil Capsules CAP 20 mg 1 x 14's (in PVC-Alu blister)	Capsule 57 CMS-PP-304578 OMESIL CAPSULES 20MG OMEPRAZOLE USP 20MG ACTIVE: Omeprazole USP 20mg LIST OF EXCIPIENTS: 1.Sugar spheres (contain sucrose and maize starch) 2. Hypromellose 3. Sodium lauryl sulfate 4. Povidone K25 5. Talc 6. Magnesium oxide heavy 7. Methacrylic acid ethyl acrylate copolymer 8. Triethyl citrate A4-4018 Drugs Imported Products 114 Prescription Only Medicine (POM) 12/16/2022 MYFIL HEALTH CARE LIMITED, 167,AKOWONJO ROAD AKOWONJO, EGBEDA, LAGOS STATE 7036395409 myfilfama@gmail.com ALCHEMY MEDICINE PVT. LTD, KHASRA NO. 44 CHUDIYALA ROAD, KHELPIJR, NASRTJLLA BHAGWANPUR, ROORKEE, DIST., HARIDWAR, UTTARAKHAND, INDIA, India	27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BC01	Omeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-4018